Strong growth for nutraceuticals group
Australian manufacturer of pharmaceuticals and nutraceuticals FH
Faulding announced this week a net profit of AU$ 106 million.
Faulding announced this week a net profit of AU$ 106 million.
Australian manufacturer of pharmaceuticals and nutraceuticals FH Faulding announced this week a net profit of AU$ 106 million (Euro61.9m), a rise of 35.4 per cent from last year. The company said in a statement that the results were helped by a particularly strong performance in the pharmaceutical division which showed a closing balance of AU$ 279 million (Euro162.9m) in June 2001 compared to AU$ 203 million (Euro118.5m) in 2000. The nutraceutical market witnessed a depression in sales with growth of only 3.6 per cent. But FH Faulding stated that moves to integrate the supply chain for the vitamins, minerals and supplements (VMS) business ensured that significant cost savings were realised.
